Quantcast

Latest Rock Creek Pharmaceutical Stories

2014-08-11 16:28:15

SARASOTA, Fla., Aug. 11, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today that it filed with the Securities Exchange Commission its Form 10-Q for the second quarter ended June 30, 2014. The company has also announced a clinical and regulatory update. http://photos.prnewswire.com/prnvar/20140811/135143 Second Quarter, 2014: For the three months ended...

2014-07-31 16:28:08

SARASOTA, Fla., July 31, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI) announced today that it has initiated the development of its lead molecule, Anatabine Citrate, in Europe; and that it has selected Quotient Clinical, The Translational Pharmaceutics Company, based in the United Kingdom (UK) to run its early development programs. http://photos.prnewswire.com/prnvar/20140731/132375 The Company expects to file a Clinical Trial Application (CTA) by the end of...

2014-06-02 16:27:48

GLEN ALLEN, Va., June 2, 2014 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) announced that the Company will formally change its corporate name to Rock Creek Pharmaceuticals, Inc. effective June 4, 2014, with a new ticker symbol of "RCPI" to begin trading on the NASDAQ effective June 4, 2014. A new corporate website will also be available June 4, 2014, with an address of www.rockcreekpharma.com. Effective upon the change of the Company's name, the Company's headquarters will...

2010-04-07 09:43:00

GLEN ALLEN, Va., April 7 /PRNewswire-FirstCall/ -- Star Scientific (Nasdaq: CIGX) announced today that it has completed a "Research and Royalty Agreement" with the Roskamp Institute's affiliate, SRQ Bio, LLC, under which the Institute will conduct research on a compound developed by the company's Rock Creek Pharmaceutical subsidiary that medical researchers at the Institute believe may have an application in the treatment of Alzheimer's disease. Preliminary testing of the compound has...

2009-01-06 07:40:00

PETERSBURG, Va., Jan. 6 /PRNewswire-FirstCall/ -- Star Scientific (Nasdaq: STSI) announced today that its subsidiary, Rock Creek Pharmaceuticals, Inc., in conjunction with its Star Tobacco, Inc. subsidiary, recently completed a study to determine the ability of Stonewall(R) dissolvable smokeless tobacco to relieve cigarette withdrawal symptoms when compared to an over-the-counter nicotine replacement product (NRT). The study, which included 49 cigarette smokers, was designed to measure 1)...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related